All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

Nycomed loses out in Solvay bid

Abbot Laboratories stepped in to buy the Eu4.5bn pharmaceutical unit of Solvay on Monday night, scuppering a potential leveraged financing for private equity-backed Nycomed.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree